The paradox of NKp46+natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment

Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+T-cell immunity

(2012) Tom Pembroke et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis c virus immunity

(2012) Lucy Golden-Mason et al.   HEPATOLOGY

Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection

(2012) Stefania Varchetta et al.   HEPATOLOGY

Natural killer p46Highexpression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis

(2012) Benjamin Krämer et al.   HEPATOLOGY

Tuning of Natural Killer Cell Reactivity by NKp46 and Helios Calibrates T Cell Responses

(2012) E. Narni-Mancinelli et al.   SCIENCE

Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment

(2011) Federica Bozzano et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

A Polymorphism in IL28B Distinguishes Exposed, Uninfected Individuals From Spontaneous Resolvers of HCV Infection

(2011) Susanne Knapp et al.   GASTROENTEROLOGY

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients

(2011) Birgit Edlich et al.   HEPATOLOGY

Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin

(2011) Mostafa Jarahian et al.   PLoS Pathogens

Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment

(2010) Omar Dessouki et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro

(2010) Lucy Golden-Mason et al.   HEPATOLOGY

Innate immunity defines the capacity of antiviral T cells to limit persistent infection

(2010) Daniel M. Andrews et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines

(2010) Damien Sène et al.   PLoS Pathogens

Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections

(2009) Barbara Oliviero et al.   GASTROENTEROLOGY

Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner

(2009) Golo Ahlenstiel et al.   GASTROENTEROLOGY

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

(2009) Cameron S. Brandt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C

(2009) Paula Bonorino et al.   JOURNAL OF HEPATOLOGY

Sustained response to interferon-α plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells

(2008) Satoshi Yamagiwa et al.   HEPATOLOGY RESEARCH

Interferon signaling and treatment outcome in chronic hepatitis C

(2008) M. Sarasin-Filipowicz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA